The mission of the OSUCCC Proteomics Shared Resource (PSR) is to advance the quality of cancer research while increasing productivity of OSUCCC members at reduced costs through providing high quality instrumentation and expert resources. The PSR provides instrumentation, scientific expertise and shared research services needed for the identification of proteins, protein modifications and protein biomarkers. The methods in proteomic analysis supported by the PSR include protein extraction from biopsies or ce cu tures, 2- dimensional protein separation, protein identification by MALDI-TOF and electrospray ionization coupled with liquid chromatography (LC) mass spectrometry and database searching, protein quantification through image analysis of 2D-gels and protein pattern recognition by SELDI-TOF mass spectrometry for serum analyses. The PSR is designed to provide affordable and high quality service in each of these areas, based on a cost-effective charge-back system. Under the leadership of Dr. Ming-Daw Tsai, the PSR facility provides technical expertise for OSUCCC researchers to submit samples for proteomic analysis as well as a collaborative environment for researchers to discuss with the PSR staff on how to solve a research problem using cutting-edge technology so that these researchers can more effectively and efficiently solve problems of chemical and protein biomarker and diagnosis on cancer samp es and research projects. Since 1999, over $3.8 M of institutional support has been invested in the development of the PSR, with almost half of that amount supporting the purchase of state-of-the-part instrumentation. Although relatively new, the PSR has shown an increasing usage by OSUCCC members, now exceeding 30 members representing all 6 of the OSUCCC research programs. At present, OSUCCC member usage of the PSR represents approximately one-third of the total usage of the facility. Based on historical growth as well as planned growth from new recruitment efforts within the OSUCCC and the role proteomics is beginning to play in profiling the cancer cell, it is projected that OSUCCC members will represent more than 50% of the total PSR usage in the new project period. We now request CCSG funding for the PSR that will provide `23% of the total support for this important full Shared Resource over the next five years.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-33
Application #
7630238
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
33
Fiscal Year
2008
Total Cost
$173,973
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Shu, Yi; Yin, Hongran; Rajabi, Mehdi et al. (2018) RNA-based micelles: A novel platform for paclitaxel loading and delivery. J Control Release 276:17-29
Scoville, Steven D; Nalin, Ansel P; Chen, Luxi et al. (2018) Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function. Blood 132:1792-1804
McMillan, Elizabeth A; Ryu, Myung-Jeom; Diep, Caroline H et al. (2018) Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer. Cell 173:864-878.e29
Schimizzi, Gregory V; Jin, Linda X; Davidson 4th, Jesse T et al. (2018) Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium. HPB (Oxford) 20:332-339
Fu, Xinping; Tao, Lihua; Wang, Pin-Yi et al. (2018) Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles. Oncotarget 9:21348-21358
Brewington, Beatrice Y; Shao, Yusra F; Davidorf, Fredrick H et al. (2018) Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions. Clin Ophthalmol 12:925-934
Doogan, Nathan J; Cooper, Sarah; Quisenberry, Amanda J et al. (2018) The role of travel distance and price promotions in tobacco product purchase quantity. Health Place 51:151-157
Byrd, John C; Ruppert, Amy S; Heerema, Nyla A et al. (2018) Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance). Blood Adv 2:1705-1718
Oblinger, Janet L; Burns, Sarah S; Huang, Jie et al. (2018) Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation. Exp Neurol 299:299-307
Pan, Pan; Oshima, Kiyoko; Huang, Yi-Wen et al. (2018) Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors. Int J Cancer 143:886-896

Showing the most recent 10 out of 2602 publications